FRIDAY NOON SEMINAR: Overcoming resistance to EGFR inhibitors in non small-cell lung cancer: diverse strategies to identify novel drug combinations | www.ibmc.up.pt

search

Search form

Search

FRIDAY NOON SEMINAR: Overcoming resistance to EGFR inhibitors in non small-cell lung cancer: diverse strategies to identify novel drug combinations

Friday, December 7, 2018

Matthew Martin

Astrazeneca, United Kingdom

FRIDAY NOON SEMINAR | 07 December 2018 | 12H | Auditorium Mariano Gago
Overcoming resistance to EGFR inhibitors in non small-cell lung cancer: diverse strategies to identify novel drug combinations
Matthew Martin - Astrazeneca, United Kingdom

Home | Site Map | Contacts | Credits | Privacy & Cookies | WHISTLEBLOWER CHANNEL | Intranet | Social Networks |

rua alfredo allen, 208, 4200-135 porto - portugal | tel +351 226 074 900 | email: info@i3s.up.pt | © copyright 2010 ibmc